Mounjaro face has captured attention since Rosie O'Donnell shared her transformation on tirzepatide. Starting the GLP-1 medication in January 2023 for diabetes management, she celebrated losing 10 pounds in the first few weeks. However, side-by-side photos reveal the downside: rapid facial fat loss causing sagging skin and a gaunt appearance.
The Rise of GLP-1 Medications and Celebrity Transformations
Since GLP-1 medications like Mounjaro (tirzepatide) gained popularity around 2022, celebrities have openly discussed their weight loss journeys. These drugs mimic hormones that regulate blood sugar and appetite, leading to significant reductions in body weight. Rosie O'Donnell joined this trend, posting about her prescription on social media. While thrilled with the scale results, she encountered a common yet striking side effect known as Mounjaro face.
Tirzepatide, the active ingredient in Mounjaro, is a dual GLP-1 and GIP receptor agonist approved for type 2 diabetes and chronic weight management. It promotes satiety, slows gastric emptying, and improves insulin sensitivity. For patients like O'Donnell, who has diabetes, these mechanisms offer dual benefits: better glycemic control and weight loss. Yet, the speed of fat reduction—often 10-20% of body weight in months—can disproportionately affect the face, where fat pads provide youthful volume.
Rosie O'Donnell's Journey with Mounjaro
O'Donnell first revealed her Mounjaro prescription in January 2023, noting her doctor prescribed tirzepatide primarily for diabetes. The unexpected perk? Rapid weight loss. Within weeks, she shared shedding 10 pounds, exciting her followers. Fast-forward to side-by-side comparisons: a September 2022 photo shows her pre-medication face, full and firm. By October 2025, the changes are evident—looser skin around the mouth and cheeks, hallmarks of Mounjaro face.
This isn't isolated; rapid weight loss from GLP-1s leads to sudden facial fat pad depletion. The skin, lacking underlying support, sags, creating hollows under the eyes, nasolabial folds, and a gaunt contour. O'Donnell's case stands out due to the dramatic visual contrast over three years of use.
What is Mounjaro Face? Understanding the Science
How Tirzepatide Causes Facial Changes
Mounjaro face stems from accelerated lipolysis (fat breakdown) triggered by tirzepatide's appetite suppression and metabolic shifts. Facial fat compartments, like the malar and buccal areas, diminish faster than visceral fat because they have fewer blood vessels and less metabolic demand. This results in deflation, where skin elasticity can't keep pace, especially in those over 40 like O'Donnell.
Clinically, studies on GLP-1 agonists show 15-25% of users report facial aging concerns. The phenomenon mirrors "Ozempic face," but Mounjaro's potency—combining GLP-1 and GIP actions—may amplify it. Patients lose subcutaneous fat uniformly at first, but the face shows it prominently due to thinner skin layers.
Precision tracking for your journey
Join thousands using Shotlee to accurately track GLP-1 medications and side effects.
📱 Get the Shotlee App
Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!
Mounjaro Face vs. Ozempic Face: Key Similarities and Differences
Both terms describe the same issue: sagging, gaunt features from semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound). Ozempic face gained fame first, but Mounjaro face follows suit. Tirzepatide often yields faster weight loss (up to 22% vs. 15% for semaglutide in trials), potentially intensifying facial effects. O'Donnell's photos exemplify this, with looser perioral skin akin to Ozempic cases but striking in progression.
Expert Insights: Dr. Samuel Golpanian's Analysis
"You can see that her skin appears grayish in color," Beverly Hills plastic surgeon Dr. Samuel Golpanian told Nicki Swift in August 2025. He deemed O'Donnell the most striking case of celeb Ozempic face—or Mounjaro face in her case—not just from sagging but the overall tonal shift.
Dr. Golpanian's observation highlights hyperpigmentation or dullness from nutritional changes during rapid loss. Dehydration, collagen breakdown, and micronutrient shifts (e.g., lower antioxidants) contribute. This elevates O'Donnell's example beyond typical sagging.
Managing Mounjaro Face: Practical Guidance for Patients
If you're on Mounjaro or considering it, discuss facial changes with your doctor. Strategies include:
- Slow titration: Start low (2.5mg weekly) to minimize rapid loss.
- Hydration and nutrition: Prioritize protein (1.2-1.6g/kg body weight), collagen supplements, and hyaluronic acid for skin plumpness.
- Skincare: Retinoids, vitamin C serums, and gua sha to boost circulation.
- Strength training: Preserve muscle mass to support skin.
- Monitoring tools: Apps like Shotlee can track side effects, symptoms, and medication adherence for proactive adjustments.
For severe cases, dermatologists recommend fillers (e.g., hyaluronic acid) or radiofrequency treatments post-stabilization. Always weigh these against Mounjaro's benefits for diabetes and obesity.
Balancing Side Effects with Long-Term Benefits
O'Donnell remains unfazed, prioritizing health gains over aesthetics. Mounjaro reduces cardiovascular risks, improves A1C by 2+ points, and aids sustained weight management. Cosmetic tweaks are reversible; diabetes complications are not. Her stance resonates: trade-offs favor metabolic health.
Safety profile: Common sides include nausea, but facial changes are cosmetic. Rare risks like pancreatitis warrant monitoring. Consult endocrinologists for personalized plans.
Key Takeaways: What This Means for Mounjaro Users
- Rosie O'Donnell's side-by-side pics from September 2022 and October 2025 showcase classic Mounjaro face: sagging cheeks, mouth, gaunt look.
- She lost 10 pounds quickly after starting tirzepatide in January 2023 for diabetes.
- Dr. Golpanian notes grayish skin, calling it the most striking celebrity case.
- Mechanism: Rapid facial fat loss from GLP-1/GIP action.
- Manage with nutrition, skincare; benefits outweigh cosmetics for many.
Conclusion: Informed Choices for GLP-1 Therapy
Rosie O'Donnell's Mounjaro face underscores a real side effect of transformative drugs like tirzepatide. Preserve the narrative of her positive outlook while preparing for changes. Speak to your healthcare provider about risks, mitigation, and if Mounjaro fits your metabolic health goals. Track progress diligently for optimal outcomes.
